| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/22/2007 | WO2006116631A3 Cancer specific pcna isoform binding antibodies and uses thereof |
| 03/22/2007 | WO2006113897A3 Products and methods for in vivo secretion of monatin |
| 03/22/2007 | WO2006096800A3 Immunogenic t cell targets in autoimmune hepatitis and methods of use |
| 03/22/2007 | WO2006093529A3 Covalent tethering of functional groups to proteins and substrates therefor |
| 03/22/2007 | WO2006092385A3 Use of xcr1 for diagnosing or monitoring of immune tolerance |
| 03/22/2007 | WO2006091214A3 Fluorescent isotope tags and their method of use |
| 03/22/2007 | WO2006090073A3 Method and device for separating molecular targets in a complex mixture |
| 03/22/2007 | WO2006083516A9 Modified cyanovirin-n polypeptide |
| 03/22/2007 | WO2006067742A3 Immortalized endothelial cells |
| 03/22/2007 | WO2006065118A3 Chromatographic analyse-devices and test kits |
| 03/22/2007 | WO2006036179A3 Frizzled proteins and detection and treatment of cancer |
| 03/22/2007 | WO2006031544A3 Methods for detection of pathogens in red blood cells |
| 03/22/2007 | WO2006023893A3 Methods for modulating angiogenesis and apoptosis with apelin compositions |
| 03/22/2007 | WO2005108990A3 Methods of treating demyelinating disorders |
| 03/22/2007 | WO2005094363A3 System, method and software arrangement for bi-allele haplotype phasing |
| 03/22/2007 | WO2005092377A9 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 03/22/2007 | WO2005008450A3 Method and apparatus for nanogap device and array |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066809 Monoclonal antibodies to gastrin hormone |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066558 Molecular determinants of myeloma bone disease and use thereof |
| 03/22/2007 | US20070066543 Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
| 03/22/2007 | US20070066540 Growth Hormone Secretagogue Receptor Type 1A Agonists |
| 03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070065954 Surface plasmon resonance biosensor system for detection of antigens and method for determining the presence of antigens |
| 03/22/2007 | US20070065953 Methods for reducing the range in concentrations of analyte species in a sample |
| 03/22/2007 | US20070065952 Multi-directional immunochromatographic assays |
| 03/22/2007 | US20070065949 Method and apparatus for desorption and ionization of analytes |
| 03/22/2007 | US20070065948 Use of antibody-surrogate antigen systems for detection of analytes |
| 03/22/2007 | US20070065947 Printing liquid solution arrays for inorganic combinatorial libraries |
| 03/22/2007 | US20070065946 Method and device for the analysis of living reaction media |
| 03/22/2007 | US20070065935 Polymeric microarray support, method of forming microfeatures on an optical assay arrangement |
| 03/22/2007 | US20070065921 Methods and products related to producing low molecular weight heparin |
| 03/22/2007 | US20070065918 Purified mammalian cytokines; related reagents and methods |
| 03/22/2007 | US20070065917 Endogenous and non-endogenous, constitutively activated human G protein-coupled receptions |
| 03/22/2007 | US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels |
| 03/22/2007 | US20070065896 Methods and kits for quantifying metabolites or analytes |
| 03/22/2007 | US20070065891 Method of pretreating sample and immunological assay method using the same |
| 03/22/2007 | US20070065890 Method for promoting formation of facultative heterochromatin |
| 03/22/2007 | US20070065889 Compositions and methods to diagnose and treat lung cancer |
| 03/22/2007 | US20070065888 Reagents and methods for use in cancer diagnosis, classification and therapy |
| 03/22/2007 | US20070065887 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 03/22/2007 | US20070065886 Antibodies and methods for predicting dental caries |
| 03/22/2007 | US20070065885 Methods for shp1 mediated neuroprotection |
| 03/22/2007 | US20070065884 Mammalian sour/acid taste and CSF receptor genes, polypeptides and assays |
| 03/22/2007 | US20070065883 Molecules that modulate Galphaq activity and methods of treating urinary incontinence |
| 03/22/2007 | US20070065882 Acetylcholinesterase-derived peptides and uses thereof |
| 03/22/2007 | US20070065881 isolating heterocomplex GM2AP/GM2/MRP14 and mutated GM2AP/GM2/MRP14; gliotoxic |
| 03/22/2007 | US20070065879 Marker for inflammatory conditions |
| 03/22/2007 | US20070065876 Marking |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065872 Apparatus and methods for detecting DNA in biological samples |
| 03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
| 03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
| 03/22/2007 | US20070065869 Methods for producing ligand arrays |
| 03/22/2007 | US20070065859 Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
| 03/22/2007 | US20070065858 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 03/22/2007 | US20070065856 determining expression of a panel of 8 specific biomarker genes; using overexpression of some of these marker genes compared to their expression in normal prostate tissue and the underexpression of the rest of these marker genes are indicative of cancerous prostate tissue |
| 03/22/2007 | US20070065850 Method for diagnosis of heart failure |
| 03/22/2007 | US20070065849 Nucleic acid encoding eosinophil eotaxin receptor |
| 03/22/2007 | US20070065848 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
| 03/22/2007 | US20070065846 Gene expression profiling in biopsied tumor tissues |
| 03/22/2007 | US20070065845 Gene expression profiling in biopsied tumor tissues |
| 03/22/2007 | US20070065842 Detection of survivin in the biological fluids of cancer patients |
| 03/22/2007 | US20070065829 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto |
| 03/22/2007 | US20070065827 Gene expression profiles and methods of use |
| 03/22/2007 | US20070065826 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same |
| 03/22/2007 | US20070065825 pulsing blood cells present in the whole blood sample of step with an identical/similar and/or different immunomodulatory agent as present in the subject using a device or kit; diagnosis/prognosis/monitoring of a clinical status affecting the immune system |
| 03/22/2007 | US20070065822 Substrates for spatially selective micron and nanometer scale deposition and combinatorial modification and fabrication |
| 03/22/2007 | US20070065821 Methods for the prediction of suicidality during treatment |
| 03/22/2007 | US20070065820 Lipid-associated molecules |
| 03/22/2007 | US20070065818 encoded by an isolated nucleic acid; a culture product; bioassay for determining the intracellular calcium concentration; immunoassay; bioluminescence resonance energy transfer (BRET) system |
| 03/22/2007 | US20070065811 Method of detecting multiple analytes |
| 03/22/2007 | US20070065810 Diagnosis and treatment of cervical cancer |
| 03/22/2007 | US20070065809 Compositions and methods screening using populations of surrogate antibodies |
| 03/22/2007 | US20070065803 Patterns for a skeletal system |
| 03/22/2007 | US20070065802 Method and system for measuring the penetration of drugs and other substances into tissue |
| 03/22/2007 | US20070065801 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (seotonin) receptor 4 (5-ht4) |
| 03/22/2007 | US20070065651 Articles with protruding conductive coatings |
| 03/22/2007 | US20070065490 Substrates and compounds bonded thereto |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065450 Transcription factor as repressor of expression of E-cadherin; drug screening |
| 03/22/2007 | US20070065446 Anti-bambi antibody and diagnostic or remedy for colon cancer and liver cancer |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065438 Methods of inducing and maintaining immune tolerance |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065428 Early B-cell detection for selecting vaccines |
| 03/22/2007 | US20070065427 Agents that modulate immune cell activation and methods of use thereof |
| 03/22/2007 | US20070065410 E4 or F4 and Bcl-2 peptides of small dimension (less than 30 amino acids) that bind a PP2A holoenzyme or one of its sub-units, particularly useful as anticancer, antiviral and antiparasitic agents |
| 03/22/2007 | US20070065405 Uses of human Zven proteins and polynucleotides |
| 03/22/2007 | US20070065404 Uses of humans zven proteins and polynucleotides |
| 03/22/2007 | US20070065403 Uses of human Zven proteins and polynucleotides |
| 03/22/2007 | US20070065362 Gastrin receptor-avid peptide conjugates |
| 03/22/2007 | US20070065345 Manufacturable single-chip hydrogen sensor |